These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26156209)

  • 1. A Computational Approach for Designing a Universal Epitope-Based Peptide Vaccine Against Nipah Virus.
    Ali MT; Morshed MM; Hassan F
    Interdiscip Sci; 2015 Jun; 7(2):177-85. PubMed ID: 26156209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial F-G Immunogens as Nipah and Respiratory Syncytial Virus Vaccine Candidates.
    Isaacs A; Cheung STM; Thakur N; Jaberolansar N; Young A; Modhiran N; Bailey D; Graham SP; Young PR; Chappell KJ; Watterson D
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases.
    Oyarzun P; Ellis JJ; Gonzalez-Galarza FF; Jones AR; Middleton D; Boden M; Kobe B
    Vaccine; 2015 Mar; 33(10):1267-73. PubMed ID: 25629524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Immunoinformatic-Based In Silico Identification on the Creation of a Multiepitope-Based Vaccination Against the Nipah Virus.
    Kaur B; Karnwal A; Bansal A; Malik T
    Biomed Res Int; 2024; 2024():4066641. PubMed ID: 38962403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope-Based Peptide Vaccine against Glycoprotein G of Nipah
    Mohammed AA; Shantier SW; Mustafa MI; Osman HK; Elmansi HE; Osman IA; Mohammed RA; Abdelrhman FA; Elnnewery ME; Yousif EM; Mustafa MM; Elfadol NM; Abdalla AI; Mahmoud E; Yagaub AA; Ahmed YA; Hassan MA
    J Immunol Res; 2020; 2020():2567957. PubMed ID: 32377531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteome Based Approach Defines Candidates for Designing a Multitope Vaccine against the Nipah Virus.
    Soltan MA; Eldeen MA; Elbassiouny N; Mohamed I; El-Damasy DA; Fayad E; Abu Ali OA; Raafat N; Eid RA; Al-Karmalawy AA
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the structural basis to develop efficient multi-epitope vaccines displaying interaction with HLA and TAP and TLR3 molecules to prevent NIPAH infection, a global threat to human health.
    Srivastava S; Verma S; Kamthania M; Saxena AK; Pandey KC; Pande V; Kolbe M
    PLoS One; 2023; 18(3):e0282580. PubMed ID: 36920996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development.
    Loomis RJ; Stewart-Jones GBE; Tsybovsky Y; Caringal RT; Morabito KM; McLellan JS; Chamberlain AL; Nugent ST; Hutchinson GB; Kueltzo LA; Mascola JR; Graham BS
    Front Immunol; 2020; 11():842. PubMed ID: 32595632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nipah virus: vaccination and passive protection studies in a hamster model.
    Guillaume V; Contamin H; Loth P; Georges-Courbot MC; Lefeuvre A; Marianneau P; Chua KB; Lam SK; Buckland R; Deubel V; Wild TF
    J Virol; 2004 Jan; 78(2):834-40. PubMed ID: 14694115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of DNA immunization with F and G protein genes of Nipah virus.
    Wang X; Ge J; Hu S; Wang Q; Wen Z; Chen H; Bu Z
    Ann N Y Acad Sci; 2006 Oct; 1081():243-5. PubMed ID: 17135518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease.
    Prescott J; DeBuysscher BL; Feldmann F; Gardner DJ; Haddock E; Martellaro C; Scott D; Feldmann H
    Vaccine; 2015 Jun; 33(24):2823-9. PubMed ID: 25865472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-epitope vaccine design using in silico analysis of glycoprotein and nucleocapsid of NIPAH virus.
    Kumar A; Misra G; Mohandas S; Yadav PD
    PLoS One; 2024; 19(5):e0300507. PubMed ID: 38728300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months.
    Pallister JA; Klein R; Arkinstall R; Haining J; Long F; White JR; Payne J; Feng YR; Wang LF; Broder CC; Middleton D
    Virol J; 2013 Jul; 10():237. PubMed ID: 23867060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge.
    Yoneda M; Georges-Courbot MC; Ikeda F; Ishii M; Nagata N; Jacquot F; Raoul H; Sato H; Kai C
    PLoS One; 2013; 8(3):e58414. PubMed ID: 23516477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice.
    Li Y; Li R; Wang M; Liu Y; Yin Y; Zai X; Song X; Chen Y; Xu J; Chen W
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32340278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities.
    Nie J; Liu L; Wang Q; Chen R; Ning T; Liu Q; Huang W; Wang Y
    Emerg Microbes Infect; 2019; 8(1):272-281. PubMed ID: 30866781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.
    DeBuysscher BL; Scott D; Marzi A; Prescott J; Feldmann H
    Vaccine; 2014 May; 32(22):2637-44. PubMed ID: 24631094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses in mice and pigs after oral vaccination with rabies virus vectored Nipah disease vaccines.
    Shuai L; Ge J; Wen Z; Wang J; Wang X; Bu Z
    Vet Microbiol; 2020 Feb; 241():108549. PubMed ID: 31928698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach.
    Oany AR; Emran AA; Jyoti TP
    Drug Des Devel Ther; 2014; 8():1139-49. PubMed ID: 25187696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell Epitope-based Vaccine Design for Nipah Virus by Reverse Vaccinology Approach.
    Krishnamoorthy PKP; Subasree S; Arthi U; Mobashir M; Gowda C; Revanasiddappa PD
    Comb Chem High Throughput Screen; 2020; 23(8):788-796. PubMed ID: 32338213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.